Centivax begins participant dosing in Phase Ia flu vaccine trial

Centivax has commenced participant dosing in its Phase Ia clinical trial, assessing Centi-Flu 01, a pan-influenza universal ...

Moderna Receives Refusal-to-File Letter from the U.S. Food and Drug Administration for Its Investigational Seasonal Influenza Vaccine, mRNA-1010

Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
Pulmonology Advisor

Substantial Number of Older Adults Do Not Think They Need Influenza, COVID-19 Vaccines

HealthDay News — More than four in 10 people older than 50 years (42 percent) have not gotten either a flu or COVID-19 vaccine, according to the results of a survey conducted by the University of ...

FDA defends its decision to refuse Moderna's flu vaccine review

By Mariam Sunny and Michael Erman Feb 11 (Reuters) - A U.S. Food and Drug Administration official on Wednesday defended the ...